FR2430236A1 - Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes - Google Patents

Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes

Info

Publication number
FR2430236A1
FR2430236A1 FR7913264A FR7913264A FR2430236A1 FR 2430236 A1 FR2430236 A1 FR 2430236A1 FR 7913264 A FR7913264 A FR 7913264A FR 7913264 A FR7913264 A FR 7913264A FR 2430236 A1 FR2430236 A1 FR 2430236A1
Authority
FR
France
Prior art keywords
technetium
compounds
reducing
labeled
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913264A
Other languages
English (en)
Other versions
FR2430236B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
New England Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp filed Critical New England Nuclear Corp
Publication of FR2430236A1 publication Critical patent/FR2430236A1/fr
Application granted granted Critical
Publication of FR2430236B1 publication Critical patent/FR2430236B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G99/00—Subject matter not provided for in other groups of this subclass
    • C01G99/006—Compounds containing, besides a metal not provided for elsewhere in this subclass, two or more other elements other than oxygen or hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des compositions destinées à réduire le technétium pour former des ligands marqués au technétium, qui comprennent un substrat acceptable du point de vue pharmacologique auquel est lié un complexe réducteur dont le potentiel d'oxydo-réduction est suffisant pour réduire le technétium à partir du degré d'oxydation + 7. Le complexe réducteur comprend de préférence un agent réducteur du technétium et un ligand chélateur correspondant. Des ligands marqués au technétium sont préparés par mélange de ces ligands avec un pertechnétate en présence du réducteur de l'invention, puis séparation du réducteur et du ligand marqué résultant. On peut préparer de la sorte des ligands marqués au technétium qui sont sensiblement dépourvus de l'agent réducteur utilisé dans leur préparation. Applications radiopharmaceutiques.
FR7913264A 1978-05-25 1979-05-23 Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes Granted FR2430236A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/909,385 US4272503A (en) 1978-05-25 1978-05-25 Reductant composition for technetium-99m and method for making technetium-99m labelled ligands

Publications (2)

Publication Number Publication Date
FR2430236A1 true FR2430236A1 (fr) 1980-02-01
FR2430236B1 FR2430236B1 (fr) 1983-05-13

Family

ID=25427158

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913264A Granted FR2430236A1 (fr) 1978-05-25 1979-05-23 Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes

Country Status (10)

Country Link
US (1) US4272503A (fr)
JP (2) JPS54160305A (fr)
BE (1) BE876562A (fr)
CA (1) CA1111765A (fr)
CH (1) CH649924A5 (fr)
DE (1) DE2920770A1 (fr)
FR (1) FR2430236A1 (fr)
GB (1) GB2023327B (fr)
NL (1) NL7904059A (fr)
SE (1) SE7904316L (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
NL8204108A (nl) * 1981-10-27 1983-05-16 Hybritech Inc In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen.
DE3237573A1 (de) * 1982-10-09 1984-04-12 Hoechst Ag, 6230 Frankfurt Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
EP0163701A1 (fr) * 1983-12-06 1985-12-11 The Royal Melbourne Hospital PREPARATION DE PRODUITS RADIOPHARMACEUTIQUES A BASE DE TECHNETIUM-99m/
USRE38435E1 (en) * 1983-12-28 2004-02-24 Daicel Chemical Industries, Ltd. Separating agent
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US5059541A (en) * 1988-04-29 1991-10-22 Neorx Corporation Minimal derivatization of proteins
US5208007A (en) * 1988-11-22 1993-05-04 Board Of Regents Of The University Of Oklahoma Isotopic tracer composition and method for making and using same
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
JPH08508500A (ja) * 1993-03-31 1996-09-10 マリンクロット・メディカル・インコーポレイテッド 非第一スズ還元剤を有する放射性薬剤
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
JP4293632B2 (ja) * 1993-11-16 2009-07-08 ブラッコ インターナショナル ベースローテン フェンノートシャップ 固定化標識方法
US5774782A (en) * 1996-05-22 1998-06-30 Lockheed Martin Energy Systems, Inc. Technetium-99m generator system
US6783672B2 (en) * 2001-01-18 2004-08-31 Kemmons A. Tubbs Integrated high throughput system for the mass spectrometry of biomolecules
US7799526B2 (en) * 2002-11-21 2010-09-21 The University Of North Carolina At Chapel Hill Phosphoprotein detection reagent and methods of making and using the same
GB0804406D0 (en) * 2008-03-10 2008-04-16 Univ Zuerich Metal complexes
KR101752023B1 (ko) * 2010-02-05 2017-06-28 나믹스 가부시끼가이샤 금속 도전성 페이스트용의 환원제 조성물

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127809A1 (en) * 1971-06-01 1972-12-14 Kort, Waiter, Dr , 1000 Berlin Radioactive technetium-iron complex - for scintigraphy of organs and blood vessels
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
DE2419310A1 (de) * 1973-04-23 1974-11-07 Minnesota Mining & Mfg Technetium-markierte komplexe, verfahren zu deren herstellung und deren anwendung
DE2166643A1 (de) * 1971-03-25 1975-01-30 Minnesota Mining & Mfg Verfahren zum radioaktiven kennzeichnen von pharmazeutisch unbedenklichen mikropartikeln
FR2322586A1 (fr) * 1975-09-02 1977-04-01 Research Corp Nouveaux chelates radiopharmaceutiques et procede de formation d'une image externe
DE2543351A1 (de) * 1975-09-29 1977-04-07 Henkel & Cie Gmbh Praeparate zur herstellung von 99m technetum-radiodiagnostika

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784453A (en) * 1970-12-16 1974-01-08 H Dworkin Process and apparatus for making radioactive labeled protein material
US3873680A (en) * 1972-08-30 1975-03-25 Minnesota Mining & Mfg Mercaptan and thioketal complexes of technetium 99M for diagnostic scanning

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2166643A1 (de) * 1971-03-25 1975-01-30 Minnesota Mining & Mfg Verfahren zum radioaktiven kennzeichnen von pharmazeutisch unbedenklichen mikropartikeln
DE2127809A1 (en) * 1971-06-01 1972-12-14 Kort, Waiter, Dr , 1000 Berlin Radioactive technetium-iron complex - for scintigraphy of organs and blood vessels
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
DE2419310A1 (de) * 1973-04-23 1974-11-07 Minnesota Mining & Mfg Technetium-markierte komplexe, verfahren zu deren herstellung und deren anwendung
FR2322586A1 (fr) * 1975-09-02 1977-04-01 Research Corp Nouveaux chelates radiopharmaceutiques et procede de formation d'une image externe
DE2543351A1 (de) * 1975-09-29 1977-04-07 Henkel & Cie Gmbh Praeparate zur herstellung von 99m technetum-radiodiagnostika

Also Published As

Publication number Publication date
DE2920770A1 (de) 1979-11-29
FR2430236B1 (fr) 1983-05-13
JPS54160305A (en) 1979-12-19
NL7904059A (nl) 1979-11-27
CA1111765A (fr) 1981-11-03
GB2023327B (en) 1982-08-25
JPS58146514A (ja) 1983-09-01
GB2023327A (en) 1979-12-28
SE7904316L (sv) 1979-11-26
CH649924A5 (de) 1985-06-28
US4272503A (en) 1981-06-09
BE876562A (fr) 1979-11-26

Similar Documents

Publication Publication Date Title
FR2430236A1 (fr) Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes
DE68924795T2 (de) Verfahren zur Radiomarkierung von Proteinen.
DE69030025T2 (de) Verfahren zur Markierung von Proteinen mit Technetium/Rhenium
DK395484D0 (da) Bisamid-bisthiolforbindelser samt radiofarmaceutiske praeparater indeoldende disse
BE905138A (fr) Additif granulaire de detergent, procedes pour le preparer et composition detergente le contenant.
ATE45143T1 (de) Radiodiagnostische mittel.
FR2354777A1 (fr) Compositions pharmaceutiques contenant un extrait purifie de racines de ginseng et procede de preparation d'un tel extrait.
WO1992000759A3 (fr) Complexes radiopharmaceutiques therapeutiques stabilises
WO1989008657A3 (fr) Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques
NL7510194A (nl) Met technetium 99-m gemerkte radiodiagnostische middelen en werkwijze voor het bereiden daarvan alsmede werkwijze voor het bereiden van een sta- biele niet-radioactieve drager.
EP0527755A1 (fr) Procede ameliore de radiomarquage de fragments d'anticorps monovalents
JPH0233692B2 (fr)
BE894825A (fr) Complexes d'inclusion de steroides avec de la alpha-cyclodextrine procede pour leur preparation et compositions pharmaceutiques les contenant
GB1438919A (en) Compositions comprising chelated radioactive heave metals
FR2406873A1 (fr) Generateur perfectionne pour la production du technetium-99
EP0412012A1 (fr) Marquage de polypeptides au technetium 99m et applications en imagerie
FR2418648A1 (fr) Procede et recipient pour la preparation d'agents de diagnostic renfermant un isotope du technetium
BE779158A (fr) Perfectionnements relatifs a des procedes et des elements en vue d'eliminer des ions de metaux lourds de liquides en contenant
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
EP0419538A1 (fr) Technetium (iii/ii) utilise comme agent d'imagerie
Pessayre et al. Cumulative effects of repeated doses of compounds transformed into reactive metabolites
BE1003311A5 (fr) Composition pharmaceutique.
FR2422397A1 (fr) Procede de preparation d'une substance scintigraphique
Vilček et al. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent
Srivastava et al. Recent developments in blood cell labeling research

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
ST Notification of lapse